Gene · 3783
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional Repression of CCL2 by KCa3.1 K+ Channel Activation and LRRC8A Anion Channel Inhibition in THP-1-Differentiated M2 Macrophages. | Int J Mol Sci | 2025 | 40806751 | PubTator, text mining | PubMed |
| Integrated multiple machine learning and Mendelian randomization reveal LTF gene as a prognostic biomarker for nonspecific orbital inflammation. | BMC Pharmacol Toxicol | 2025 | 40760708 | PubTator, text mining | PubMed |
| Learning factors influencing second language proficiency: a cross-cultural comparative study of English and Chinese L2 learners. | BMC Psychol | 2025 | 40745337 | PubTator, text mining | PubMed |
| Dominant ionic currents in rabbit ventricular action potential dynamics. | PLoS One | 2025 | 40737342 | PubTator, text mining | PubMed |
| In Silico Analysis of Post-COVID-19 Condition (PCC) Associated SNP rs9367106 Predicts the Molecular Basis of Abnormalities in the Lungs and Brain Functions. | Int J Mol Sci | 2025 | 40724930 | PubTator, text mining | PubMed |
| VX-445 (elexacaftor) inhibits chloride secretion across human bronchial epithelial cells by directly blocking KCa3.1 channels. | PNAS Nexus | 2025 | 40688096 | PubTator, text mining | PubMed |
| Exploring the Mechanisms of Lijin Fang on Treg/Th17 Cell Imbalance in COPD Based on Network Pharmacology. | Int J Chron Obstruct Pulmon Dis | 2025 | 40641910 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals the impact of thrombotic diseases on the occurrence and prognosis of breast cancer. | J Steroid Biochem Mol Biol | 2025 | 40513964 | PubTator, text mining | PubMed |
| Causal relationships between alterations in shear stress-related genes and aneurysmal subarachnoid hemorrhage. | Orphanet J Rare Dis | 2025 | 40500739 | PubTator, text mining | PubMed |
| Targeting Ca2+-activated K+ channels in glioma. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40484048 | PubTator, text mining | PubMed |
| SK4 potentially modulates the alternative splicing profile associated with papillary thyroid cancer development in BHT101 cells. | PeerJ | 2025 | 40452939 | PubTator, text mining | PubMed |
| KCNN4-mediated potassium ion efflux maintains mitochondrial functions leading to platelet biogenesis. | J Thromb Haemost | 2025 | 40412718 | PubTator, text mining | PubMed |
| Role of CAR-T cell K+ channels in tumor infiltration and elimination. | J Immunol | 2025 | 40373182 | PubTator, text mining | PubMed |
| Repurposing of modafinil as an anti-inflammatory drug: a systematic review of experimental studies. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 40358683 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma. | Commun Biol | 2025 | 40295632 | PubTator, text mining | PubMed |
| Design and structural basis of selective 1,4-dihydropyridine inhibitors of the calcium-activated potassium channel KCa3.1. | Proc Natl Acad Sci U S A | 2025 | 40294255 | PubTator, text mining | PubMed |
| RvD1 and LXA4 inhibitory effects on cardiac voltage-gated potassium channels. | Biomed Pharmacother | 2025 | 40273690 | PubTator, text mining | PubMed |
| The evolving landscape of hereditary stomatocytosis. | Blood | 2025 | 40233304 | PubTator, text mining | PubMed |
| KCa3.1 Contributes to Neuroinflammation and Nigral Dopaminergic Neurodegeneration in Experimental models of Parkinson's Disease. | bioRxiv | 2025 | 40166152 | PubTator, text mining | PubMed |
| Developing an IPF Prognostic Model and Screening for Key Genes Based on Cold Exposure-Related Genes Using Bioinformatics Approaches. | Biomedicines | 2025 | 40149666 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3783/papers?page=5